As of 2025-04-29, the Relative Valuation of Mirum Pharmaceuticals Inc (MIRM) is (20.67) USD. This relative valuation is based on P/E multiples. With the latest stock price at 41.31 USD, the upside of Mirum Pharmaceuticals Inc based on Relative Valuation is -150.0%.
The range of the Relative Valuation is (17.43) - (25.08) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 7.5x - 15.1x | 11.3x |
| Forward P/E multiples | 9.8x - 14.1x | 12.0x |
| Fair Price | (17.43) - (25.08) | (20.67) |
| Upside | -142.2% - -160.7% | -150.0% |
| Date | P/E |
| 2025-04-25 | -22.94 |
| 2025-04-24 | -22.76 |
| 2025-04-23 | -22.28 |
| 2025-04-22 | -22.17 |
| 2025-04-21 | -21.59 |
| 2025-04-17 | -21.99 |
| 2025-04-16 | -21.79 |
| 2025-04-15 | -21.72 |
| 2025-04-14 | -22.26 |
| 2025-04-11 | -22.26 |
| 2025-04-10 | -22.00 |
| 2025-04-09 | -23.32 |
| 2025-04-08 | -22.11 |
| 2025-04-07 | -23.05 |
| 2025-04-04 | -23.63 |
| 2025-04-03 | -24.31 |
| 2025-04-02 | -25.30 |
| 2025-04-01 | -24.76 |
| 2025-03-31 | -25.33 |
| 2025-03-28 | -25.86 |
| 2025-03-27 | -25.91 |
| 2025-03-26 | -26.02 |
| 2025-03-25 | -26.46 |
| 2025-03-24 | -26.44 |
| 2025-03-21 | -26.44 |
| 2025-03-20 | -26.92 |
| 2025-03-19 | -26.50 |
| 2025-03-18 | -24.92 |
| 2025-03-17 | -25.39 |
| 2025-03-14 | -24.90 |
| 2025-03-13 | -25.06 |
| 2025-03-12 | -25.32 |
| 2025-03-11 | -24.78 |
| 2025-03-10 | -24.18 |
| 2025-03-07 | -24.44 |
| 2025-03-06 | -24.42 |
| 2025-03-05 | -25.10 |
| 2025-03-04 | -25.43 |
| 2025-03-03 | -25.86 |
| 2025-02-28 | -26.75 |
| 2025-02-27 | -26.41 |
| 2025-02-26 | -28.41 |
| 2025-02-25 | -28.08 |
| 2025-02-24 | -28.65 |
| 2025-02-21 | -29.49 |
| 2025-02-20 | -29.89 |
| 2025-02-19 | -29.34 |
| 2025-02-18 | -29.63 |
| 2025-02-14 | -28.14 |
| 2025-02-13 | -28.51 |